Topical eye drops have traditionally been a mainstay in the postoperative care of cataract surgery, but dropless cataract surgery (DCS) now offers a viable alternative by administering medications intraoperatively. This shift addresses compliance issues inherent in traditional drop regimens, particularly for elderly patients experiencing challenges with medication administration. Evidence, including recent guidelines from the UKISCRS, suggests that DCS effectively improves patient outcomes, reduces healthcare costs, and aligns practice with sustainability goals. These recommendations emphasize the importance of intracameral antibiotics and subconjunctival corticosteroids while minimizing the reliance on postoperative drops.
False
Advertisement
False
Advertisement